Immunotherapy boosts standard care for returning throat cancer
NCT ID NCT03907826
First seen May 10, 2026 · Last updated May 21, 2026 · Updated 2 times
Summary
This study tests whether adding an immunotherapy drug (PD-1 antibody) to standard chemoradiotherapy helps people with recurrent nasopharyngeal cancer live longer. About 212 adults whose cancer has returned after prior treatment and who cannot have surgery will be randomly assigned to one of two groups. The goal is to see if the combination improves survival and quality of life compared to chemoradiotherapy alone.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT NASOPHARYNGEAL CARCINOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Fudan University Shanghai Cancer Center
NOT_YET_RECRUITINGShanghai, China
Contact
-
Fujian Province Cancer Hospital
NOT_YET_RECRUITINGFuzhou, China
Contact
-
Guizhou Cancer Hospital
RECRUITINGGuiyang, China
Contact
-
Jiangxi Cancer Hospital
NOT_YET_RECRUITINGNanchang, China
Contact
-
Peking University Third Hospital
NOT_YET_RECRUITINGBeijing, China
Contact
-
Sichuan Cancer Hospital
NOT_YET_RECRUITINGChengdu, China
Contact
-
Sun Yat-sen University Cancer Center
RECRUITINGGuangzhou, Guangdong, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
The First Affiliated Hospital of Guangxi Medical University
RECRUITINGNanning, China
Contact
-
The First Affiliated Hospital of Xiamen University
NOT_YET_RECRUITINGXiamen, China
Contact
-
Xijing Hospital
RECRUITINGXi'an, China
Contact
-
Zhejiang Cancer Hospital
NOT_YET_RECRUITINGHangzhou, China
Contact
-
Zhongnan Hospital of Wuhan University
RECRUITINGWuhan, China
Contact
Conditions
Explore the condition pages connected to this study.